Edge Wealth Management’s GSK GSK Stock Holding History

Edge Wealth Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,360	Closed	-$75K	–	245
2021 Q4	$75K	Hold	1,360	–	–	0.01%	149
2021 Q3	$65K	Hold	1,360	–	–	0.01%	168
2021 Q2	$67K	Hold	1,360	–	–	0.01%	167
2021 Q1	$61K	Hold	1,360	–	–	0.01%	178
2020 Q4	$62K	Hold	1,360	–	–	0.01%	166
2020 Q3	$64K	Sell	1,360 -160	-11%	-$8.02K	0.01%	183
2020 Q2	$78K	Sell	1,520 -16,000	-91%	-$821K	0.01%	231
2020 Q1	$828K	Buy	17,520 +16,000	+1,053%	+$853K	0.18%	69
2019 Q4	$89K	Hold	1,520	–	–	0.02%	208
2019 Q3	$81K	Hold	1,520	–	–	0.02%	206
2019 Q2	$76K	Hold	1,520	–	–	0.02%	214
2019 Q1	$80K	Hold	1,520	–	–	0.02%	201
2018 Q4	$73K	Hold	1,520	–	–	0.02%	212
2018 Q3	$76K	Buy	1,520 +160	+12%	+$8.13K	0.02%	221
2018 Q2	$69K	Sell	1,360 -52	-4%	-$2.62K	0.02%	216
2018 Q1	$69K	Sell	1,412 -257	-15%	-$12K	0.02%	198
2017 Q4	$74K	Hold	1,669	–	–	0.02%	186
2017 Q3	$85K	Buy	1,669 +52	+3%	+$2.64K	0.03%	181
2017 Q2	$86K	Hold	1,617	–	–	0.03%	183
2017 Q1	$85K	Hold	1,617	–	–	0.03%	177
2016 Q4	$78K	Buy	+1,617	New	+$79.9K	0.03%	165

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Edge Wealth Management's GSK Position: Q1 2022 in Review

Edge Wealth Management sold out of GSK (GSK) in Q1 2022, closing a stake of 1,360 shares — an estimated $75K sold.

Edge Wealth Management first reported a position in GSK in Q4 2016 and held it in 21 quarters. The position peaked at $828K in Q1 2020. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

Edge Wealth Management reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
Edge Wealth Management sold 1,360 GSK shares in Q1 2022, an estimated $75K.
Edge Wealth Management first reported a position in GSK in Q4 2016 and held it in 21 quarters.
Edge Wealth Management's GSK position peaked at $828K in Q1 2020.
929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Edge Wealth Management's 13F filing for Q1 2022, filed 14 Apr 2022.